World News And General News On September 26, 2021 at 01:00PM - Viral Trending News Headlines

COVID-19 in Iran: ‘Prospects Look Good’ as over 50% of Target Population Vaccinated by at Least One Dose

Sunday, 26 September 2021 6:50 PM

Press TV  

A nurse prepares to administer a COVIran Berakat vaccine against COVID-19 at a vaccination center in Shar-e Rey, near Tehran, Iran, on September 26, 2021. (Photo by YJC)

Story by Mohammad Homaeefar

More than 50 percent of Iran’s target population have received at least one dose of a COVID-19 vaccine, as the country’s vaccination rollout accelerates, made possible in part by larger foreign vaccine imports.

According to the latest statistics published by Iran’s Health Ministry on Sunday, more than 35 million people— out of the target population of 60 million — have received at least one dose of a COVID-19 vaccine, while the total number of vaccines injected has exceeded 50 million.

So far, 15,467,255 people have been fully vaccinated, according to the ministry. That includes the 1,169,478 people who have received the shot in the past 24 hours.

In recent weeks, Iran has on average rolled out more than one million doses each day, doing its utmost to make up for a lengthy delay in importing enough shots to complement the vaccination of Iranians with homegrown jabs. Leader of the Islamic Revolution Ayatollah Seyyed Ali Khamenei has said foreign vaccines poured in only after the world saw the success of Iran’s homegrown ones.

Iran is among a few West Asian countries capable of developing and producing vaccines. The Islamic Republic has developed several vaccines against COVID-19, including the COVIran Barekat, Razi COV-Pars, Noora, and Fakhra.

Iran is to receive 10 mln of J&J, Pfizer vaccines to boost immunization against the coronavirus.

According to Kayhan Azadmanesh, the head of the virology research division at the Pasteur Institute of Iran in Tehran, Iran possesses the technology and know-how of producing vaccines, “so why not use it?”

In an interview with the prestigious scientific journal Nature last month, Azadmanesh said that due to Iran’s ability to produce vaccines and in order to ensure the safety of Iranians, “it makes sense to develop a variety of vaccines using different research and development strategies, as China has done.”

The increase in vaccinations in Iran began after the administration of President Ebrahim Raeisi, who had made the provision of vaccines and the fight against the deadly virus a top priority, took charge. Faced with a pandemic that exacerbated the country’s already hard-hit economy, which has been under severe US sanctions since 2018, President Raeisi’s administration has been pressing ahead with a major vaccination drive so that the government and businesses would be able to return to normalcy.

In remarks on Saturday, the president said that 70 percent of the Iranian society would be vaccinated within days. He said vaccinating 50 million people was made possible only through “invaluable efforts.”

Iran is to dispatch health workers door-to-door to catch up on missed COVID vaccinations.

Alireza Raeisi, the spokesman for the National Headquarters for Managing and Fighting the Coronavirus, elaborated on the president’s remarks, saying that given the fast pace of vaccination, the number of people getting the first shot would soon reach 42 million, equal to 70 percent of the target population in the vaccination campaign.

“More than one million doses are now being administered daily in the country, and given that the target population consists of 60 million people (+18 years of age), when the number of first-dose vaccines reaches 42 million, 70% of the population will have been vaccinated against the coronavirus,” the spokesman explained on Saturday.

“The prospects look good,” he said, asking Iranians to register to receive jabs as soon as possible, while voicing satisfaction with the speed of the import of vaccines.

‘We can’t rely on help from the international community’

On Sunday morning, Iran received the 57th shipment of its imported vaccines, which included six million of China’s Sinopharm, making the total of its imported jabs exceed the 71 million mark.

Meanwhile, COVID-related hospitalizations and deaths are on a declining trajectory in Iran, which is facing a fifth wave of the spread of the virus that pushed the daily death record beyond 700. According to the Health Ministry, 13,792 people tested positive for the deadly virus in the last 24 hours, while 288 people lost their lives. Since it was first detected in Iran in early 2020, the coronavirus has claimed the lives of 119,360 people.

Iran’s FDO chief says J&J and Sputnik Light vaccines have been approved for emergency use.

In spite of the shortcomings, Iran has managed to vaccinate all of its prisoners.

Hosting the world’s fourth-largest refugee community, the country has also vaccinated 400,000 foreign nationals.

Meanwhile, Tehran has repeatedly denounced US sanctions for the lag in the import of vaccines. As a result of the sanctions, there have been unfulfilled shipment promises and international monetary problems facing the country. Top officials of the Islamic Republic have also slammed global powers — mostly Western ones — for hoarding vaccines and cooperating with Washington’s anti-Iran sanctions.

Earlier this month, Raeisi, the spokesman for the National Headquarters, warned the World Health Organization (WHO) of a “vaccine apartheid,” which “can be a threat to the global health.”

Still earlier, after a new analysis showed that wealthy countries will likely have about 1.2 billion extra doses available by the end of the year, the WHO criticized the wealthy nations for hoarding COVID-19 vaccines, saying it is prolonging the pandemic. Last week, United Nations Secretary General Antonio Guterres lamented the inequitable distribution of COVID-19 vaccines, describing it as an “obscenity.”

“We can’t rely on help from the international community with the pandemic,” Azadmanesh, who is developing two viral-vector vaccines through his spin-off company Humimmune Biotech, said in his interview with Nature.

Iran has launched the third phase in the clinical trial of its homegrown Fakhra coronavirus vaccine.

Referring to the United States’ sanctions against Iran, he said Washington claimed that sanctions do not affect humanitarian activities, “but when your ability to transfer money is restricted, it is difficult to buy drugs and medicines.”

“For example, the chromatography resins we need to purify vaccines are mostly produced by multinational companies that are major suppliers to the United States, so they might be afraid of selling to us,” Azadmanesh said.

“The United States says that we can apply for exemptions, but, in our experience, that hasn’t worked. But somehow, we find a way. We modify our methods, find other providers, or look for local solutions,” he said.



No comments

Thank you for reaching out to us. We are happy to receive your opinion and request. If you are need advert or sponsored post, We’re excited you’re considering advertising or sponsoring a post on our blog. Your support is what keeps us going. With the current trend, it’s very obvious content marketing is the way to go. Banner advertising and trying to get customers through Google Adwords may get you customers but it has been proven beyond doubt that Content Marketing has more lasting benefits.
We offer majorly two types of advertising:
1. Sponsored Posts: If you are really interested in publishing a sponsored post or a press release, video content, advertorial or any other kind of sponsored post, then you are at the right place.
WHAT KIND OF SPONSORED POSTS DO WE ACCEPT?
Generally, a sponsored post can be any of the following:
Press release
Advertorial
Video content
Article
Interview
This kind of post is usually written to promote you or your business. However, we do prefer posts that naturally flow with the site’s general content. This means we can also promote artists, songs, cosmetic products and things that you love of all products or services.
DURATION & BONUSES
Every sponsored article will remain live on the site as long as this website exists. The duration is indefinite! Again, we will share your post on our social media channels and our email subscribers too will get to read your article. You’re exposing your article to our: Twitter followers, Facebook fans and other social networks.

We will also try as much as possible to optimize your post for search engines as well.

Submission of Materials : Sponsored post should be well written in English language and all materials must be delivered via electronic medium. All sponsored posts must be delivered via electronic version, either on disk or e-mail on Microsoft Word unless otherwise noted.
PRICING
The price largely depends on if you’re writing the content or we’re to do that. But if your are writing the content, it is $60 per article.

2. Banner Advertising: We also offer banner advertising in various sizes and of course, our prices are flexible. you may choose to for the weekly rate or simply buy your desired number of impressions.

Technical Details And Pricing
Banner Size 300 X 250 pixels : Appears on the home page and below all pages on the site.
Banner Size 728 X 90 pixels: Appears on the top right Corner of the homepage and all pages on the site.
Large rectangle Banner Size (336x280) : Appears on the home page and below all pages on the site.
Small square (200x200) : Appears on the right side of the home page and all pages on the site.
Half page (300x600) : Appears on the right side of the home page and all pages on the site.
Portrait (300x1050) : Appears on the right side of the home page and all pages on the site.
Billboard (970x250) : Appears on the home page.

Submission of Materials : Banner ads can be in jpeg, jpg and gif format. All materials must be deliverd via electronic medium. All ads must be delivered via electronic version, either on disk or e-mail in the ordered pixel dimensions unless otherwise noted.
For advertising offers, send an email with your name,company, website, country and advert or sponsored post you want to appear on our website to omodjk(at)gmail(dot)com

Normally, we should respond within 48 hours.